New Drug May Help Keep Hodgkin Lymphoma at Bay

March 18, 2015 11:00 PM

16 0

WEDNESDAY, March 18, 2015 (HealthDay News) -- An FDA-approved drug doubled the amount of time that patients with Hodgkins lymphoma survived without any progression in their disease, a new study shows.

All of the patients also received stem cell therapy along with the drug, called brentuximab vedotin.

Read more

To category page